Catalytic activity of phospholipase A2 in serum in experimental fat embolism in pigs

European Journal of Surgery

Volumn 163, Issue 6, 1997, Pages 449-456

  Rautanen, Markku ^a,b   Gullichsen, Eero ^a   Grönroos, Juha ^a   Kuttila, Kari ^a   Nelimarkka, Olavi ^a   Niinikoski, Juha ^a   Nevalainen, Timo J ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b KANTA HÄME CENTRAL HOSPITAL   (Finland)

Author keywords

Animal model; Blood gases; Enzymes; Fat embolism; Hypoxaemia; Inflammation; Lung injury; Phospholipase A2; Pulmonary haemodynamics

Indexed keywords

PHOSPHOLIPASE A2;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FAT EMBOLISM; FEMALE; FEVER; LEUKOCYTOSIS; LUNG ARTERIOVENOUS SHUNT; LUNG ARTERY PRESSURE; LUNG EMBOLISM; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; SWINE;

ANIMALS; BIOLOGICAL MARKERS; CATALYSIS; EMBOLISM, FAT; EVALUATION STUDIES; FEMALE; HEMODYNAMIC PROCESSES; MALE; OXYGEN; PHOSPHOLIPASES A; PULMONARY EMBOLISM; RANDOM ALLOCATION; SWINE;

EID: 0030999392     PISSN: 11024151     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. 2 gene expression in human hepatoma cells by mediators of the acute phase response. J Biol Chem 1991; 266: 2647-2651.
2. Derks CM, Peters RM. The effect of shock and fat embolus on pulmonary mechanics and gas exchange. Surg Gynecol Obstet 1974; 138: 413-416.
3. 2 in the isolated, perfused guinea pig lung. Exp Lung Res 1990; 16: 323-338.
4. 2-induced pathophysiologic changes in the guinea pig lung. Am J Pathol 1990; 136: 1283-1291.
5. 2. Structural and functional changes. Am Rev Respir Dis 1991; 143: 1102-1109.
6. Fabian TC, Hoots AV, Stanford DS, Patterson CR, Mangiante EC. Fat embolism syndrome. Prospective evaluation in 92 fracture patients. Crit Care Med 1990; 18: 42-46.
7. 2 decreases surfactant phosphatidylcholine degradation by the rat lung. Biochem J 1992; 288: 407-411.
8. Gitin TA, Seidel T, Cera PJ, Glidewell OJ, Smith JL. Pulmonary microvascular fat: the significance? Crit Care Med 1993; 21: 673-677.
9. Gossling HR, Pellegrini Jr VD. Fat embolism syndrome. A review of the pathophysiology and physiological basis of treatment. Clin Orthop 1982; 165: 68-82.
10. 2 in serum and pulmonary and renal complications in acute pancreatitis. Digestion 1992; 52: 232-236.
11. 2 in hospitalized patients. Clin Chim Acta 1989; 183: 59-64.
12. Holm BA, Keicher L, Liu MY, Sokolowski J, Enhorning G. Inhibition of pulmonary surfactant function by phospholipases. J Appl Physiol 1991; 71: 317-321.
13. 2 in sheep with acute lung injury after high dose endotoxin infusion. Am Rev Respir Dis 1993; 148: 878-881.
14. 2 activity and plasma lysophosphatidylcholine levels in asthma and rhinitis and their relationship to airway sensitivity to histamine. Am Rev Respir Dis 1990; 142: 157-161.
15. 2. FEBS Lett 1991; 294: 247-251.
16. Offenstadt G, Pinta P, Masliah J, Alcindor LG, Hericord P, Amstutz P. Phospholipasic and prophospholipasic activities in bronchoalveolar lavage fluid in severe acute pulmonary disease with or without ARDS. Intens Care Med 1981; 7: 285-291.
17. Peltier LF. Fat embolism. A perspective. Clin Orthop 1988; 232: 263-270.
18. 2 - a mediator between proximal and distal effectors of inflammation, Immunol Today 1991; 12: 143-146.
19. 2 in sera of febrile patients with microbiologically or clinically documented infections. Clin Infect Dis 1993; 17: 864-870.
20. 2 and cachectin levels in adult respiratory distress syndrome and multiple-organ failure. Clin Biochem 1992; 25: 55-60.
21. 2 catalytic activity concentration in human serum and ascites. J Clin Chem Clin Biochem 1987; 25: 505-509.
22. Sevitt S. The significance and pathology of fat embolism. Ann Clin Res 1977; 9: 173-180.
23. 2-induced pulmonary and hemodynamic responses in the guinea pig. Effects of enzyme inhibitors and mediator antagonists. Am Rev Respir Dis 1990; 142: 1193-1199.
24. 2. in patients with multiple injuries. J Trauma 1990; 30: 1285-1290.
25. 2 levels: correlation with the hemodynamic and pulmonary changes in gram-negative septic shock. J Lab Clin Med 1984; 104: 873-881.
26. 2 in septic shock. Agents Actions 1986; 19: 194-202.
27. 2 in the pathobiologv of disease. Lab Invest 1986; 55: 391-404.
28. Watson AJ. Genesis of fat emboli. J Clin Pathol 1970; 23: 132-142.
29. von Wihert P, Temmensfeld M, Meyer W. Influence of septic shock upon phosphatidylcholine remodeling mechanism in rat lung. Biochim Biophys Acta 1981; 664: 487-497.